Futao Liu
机构:Peking University, National Medical Products Administration, Peking University Cancer Hospital, Ministry of Education · ORCID:0000-0003-4904-8411
发表论文 73 篇 · 总被引 623 次 · h-index 12
代表论文
- Lipophilicity-Optimized PARP-1 Tracers: Minimizing Hepatic Retention for Enhanced Target-to-Background PET Imaging (2025 · Molecular Pharmaceutics · 被引 5)
- Design, synthesis and anti-diabetic evaluation of novel PPAR agonists based on functional group-oriented strategy (2025 · European Journal of Medicinal Chemistry · 被引 1)
- Preliminary clinical investigation of 18F-(2S,4R)-4-fluoroglutamine PET/CT in the evaluation of lung cancer (2026 · European Journal of Nuclear Medicine and Molecular Imaging)
- Construction of a 89 Zr-Labeled Specific Antibody Fragment for the Noninvasive Detection of Mesothelin-Overexpressing Tumors (2026 · Molecular Pharmaceutics)
- Additional file 4 of Bioinformatics profiling of NECTIN4 in lung cancer and comparative evaluation of NECTIN4-targeted ⁶⁸Ga-N188 and ¹⁸F-FDG PET/CT (2026 · Figshare)
- Additional file 10 of Bioinformatics profiling of NECTIN4 in lung cancer and comparative evaluation of NECTIN4-targeted ⁶⁸Ga-N188 and ¹⁸F-FDG PET/CT (2026 · Figshare)